Discover open access scientific publications

Search, annotate, share and cite publications

Publications by A. Amann

P3.04-01 Combined Plasma cfDNA Mutations and a Serum Proteomic Signature May Identify Non-Responders to Anti PD-1 Treatment in NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Related publications

Can IDO Activity Predict Primary Resistance to Anti-Pd-1 Treatment in NSCLC?

Journal of Translational Medicine

Molecular Biology

English

Dynamic Metrics-Based Biomarkers to Predict Responders to Anti-Pd-1 Immunotherapy

British Journal of Cancer

Cancer Research

English

P3.17-01 PD-L1 Expression, EGFR Mutations and ALK Expression in Non-Small Cell Lung Cancer (NSCLC) Patients From Brazil

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.04-13 PD-L1-Gene Expression by nCounter Correlates With PD-L1 Protein Expression in Advanced Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

Respiratory Medicine

English

Robust Antitumor Effects of Combined Anti-Cd4-Depleting Antibody and Anti-Pd-1/Pd-L1 Immune Checkpoint Antibody Treatment in Mice

Cancer immunology research

Cancer Research

English

P3.04-16 a Seven-Gene Expression Signature Reveals Unique Immune-Phenotypes Related to Major Oncogenic-Drivers in NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Blood Monocyte Frequency May Be a Biomarker for Response to Anti–PD-1

Cancer Discovery

English

MA04.02 Responses and Durability in NSCLC Treated With Pegilodecakin and Anti-Pd-1

Journal of Thoracic Oncology

Respiratory Medicine

English

P1.09-13 Detection of Actionable Mutations in Plasma cfDNA Samples From NSCLC Patients Using a Novel Amplicon-Based Firefly NGS Assay

Journal of Thoracic Oncology

Respiratory Medicine

English